TY  - GEN
AU  - Pui,Ching-Hon
AU  - Pei,Deqing
AU  - Sandlund,John T
AU  - Campana,Dario
AU  - Ribeiro,Raul C
AU  - Razzouk,Bassem I
AU  - Rubnitz,Jeffrey E
AU  - Howard,Scott C
AU  - Hijiya,Nobuko
AU  - Jeha,Sima
AU  - Cheng,Cheng
AU  - Downing,James R
AU  - Evans,William E
AU  - Relling,Mary V
AU  - Hudson,Melissa
TI  - Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia
SN  - 0732-183X
PY  - 2005///1209
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Child
KW  - Child, Preschool
KW  - Combined Modality Therapy
KW  - Cranial Irradiation
KW  - Etoposide
KW  - administration & dosage
KW  - Female
KW  - Humans
KW  - Infant
KW  - Male
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - mortality
KW  - Prognosis
KW  - Remission Induction
KW  - Risk Factors
KW  - Survival Rate
KW  - Teniposide
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1200/JCO.2004.01.0033
ER  -